638-23-3 | (2R)-2-amino-3-[(carboxymethyl)sulfanyl]propanoic acid

Packsize	Purity	Availability	Price	Discounted Price
1g	97%	in stock	$14.00	$10.00
5g	97%	in stock	$19.00	$13.00
25g	97%	in stock	$28.00	$19.00
100g	97%	in stock	$56.00	$39.00
500g	97%	in stock	$146.00	$102.00

Description

• Catalog Number: AB71782
• Chemical Name: (2R)-2-amino-3-[(carboxymethyl)sulfanyl]propanoic acid
• CAS Number: 638-23-3
• Molecular Formula: C5H9NO4S
• Molecular Weight: 179.19426
• MDL Number: MFCD00002614
• SMILES: OC(=O)CSC[C@@H](C(=O)O)N

Computed Properties

• Complexity: 161
• Covalently-Bonded Unit Count: 1
• Defined Atom Stereocenter Count: 1
• Heavy Atom Count: 11
• Hydrogen Bond Acceptor Count: 6
• Hydrogen Bond Donor Count: 3
• Rotatable Bond Count: 5
• XLogP3: -3.1

Literature

• Synthesis, chemical identification, antioxidant capacities and immunological evaluation studies of a novel silver(I) carbocysteine complex.

  Chemico-biological interactions 20140905

• Oxidative stress and innate immunity responses in cigarette smoke stimulated nasal epithelial cells.

  Toxicology in vitro : an international journal published in association with BIBRA 20140301

• Carbocysteine regulates innate immune responses and senescence processes in cigarette smoke stimulated bronchial epithelial cells.

  Toxicology letters 20131125

• S-Carboxyethylcysteine (a constituent of Acacia seed) negatively affects casein protein utilization by rats.

  Nutrition (Burbank, Los Angeles County, Calif.) 20120701

• Drug fever due to S-carboxymethyl-L-cystein: demonstration of a causative agent with patch tests.

  The Journal of dermatology 20120601

• Cigarette smoke enhances chemotaxis via acetylation of proline-glycine-proline.

  Frontiers in bioscience (Elite edition) 20120601

• An investigation into possible xenobiotic-endobiotic inter-relationships involving the amino acid analogue drug, S-carboxymethyl-L-cysteine and plasma amino acids in humans.

  Amino acids 20120501

• S-carboxymethyl-L-cysteine.

  Drug metabolism reviews 20120501

• [Notes on syrups and dry syrups of ambroxol hydrochloride and L-carbocysteine].

  Arerugi = [Allergy] 20120501

• Carbocisteine promotes phagocytosis of apoptotic cells by alveolar macrophages.

  European journal of pharmacology 20120227

• Efficacy of combined treatment with S-carboxymethylcysteine (carbocisteine) and clarithromycin in chronic rhinosinusitis patients without nasal polyp or with small nasal polyp.

  Auris, nasus, larynx 20120201

• Disulphide linkage in mouse ST6Gal-I: determination of linkage positions and mutant analysis.

  Journal of biochemistry 20120201

• l-carbocisteine inhibits respiratory syncytial virus infection in human tracheal epithelial cells.

  Respiratory physiology & neurobiology 20120115

• S-carboxymethylcysteine inhibits adherence of Streptococcus pneumoniae to human alveolar epithelial cells.

  Journal of medical microbiology 20120101

• Carbocisteine reduces the cytotoxicity of oxaliplatin.

  Zeitschrift fur Naturforschung. C, Journal of biosciences 20120101

• [Expression and role of sugar chains on airway mucus during the exacerbation of airway inflammation].

  Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20120101

• The B°AT1 amino acid transporter from rat kidney reconstituted in liposomes: kinetics and inactivation by methylmercury.

  Biochimica et biophysica acta 20111001

• Carbocisteine protects against emphysema induced by cigarette smoke extract in rats.

  Chest 20110501

• A comprehensive understanding of thioTEPA metabolism in the mouse using UPLC-ESI-QTOFMS-based metabolomics.

  Biochemical pharmacology 20110415

• Recombinant heteromeric phenylalanine monooxygenase and the oxygenation of carbon and sulfur substrates.

  The Journal of pharmacy and pharmacology 20110401

• Identification of novel small molecule antimicrobials targeting Mycoplasma bovis.

  The Journal of antimicrobial chemotherapy 20110301

• Respiratory paradoxical adverse drug reactions associated with acetylcysteine and carbocysteine systemic use in paediatric patients: a national survey.

  PloS one 20110101

• Protein modification by dicarbonyl molecular species in neurodegenerative diseases.

  Journal of amino acids 20110101

• Inactivation by Hg2+ and methylmercury of the glutamine/amino acid transporter (ASCT2) reconstituted in liposomes: Prediction of the involvement of a CXXC motif by homology modelling.

  Biochemical pharmacology 20101015

• Comparative metabolism of cyclophosphamide and ifosfamide in the mouse using UPLC-ESI-QTOFMS-based metabolomics.

  Biochemical pharmacology 20101001

• The effect and mechanism of action of carbocysteine on airway bacterial load in rats chronically exposed to cigarette smoke.

  Respirology (Carlton, Vic.) 20101001

• Carbocisteine normalizes the viscous property of mucus through regulation of fucosylated and sialylated sugar chain on airway mucins.

  European journal of pharmacology 20100901

• Inhibitory effects of carbocisteine on type A seasonal influenza virus infection in human airway epithelial cells.

  American journal of physiology. Lung cellular and molecular physiology 20100801

• Effects of combination therapy with montelukast and carbocysteine in allergen-induced airway hyperresponsiveness and airway inflammation.

  British journal of pharmacology 20100701

• [Mucolytic drugs: towards a contraindication in infants].

  Archives de pediatrie : organe officiel de la Societe francaise de pediatrie 20100601

• Post-translational activation of human phenylalanine 4-monooxygenase from an endobiotic to a xenobiotic enzyme by reactive oxygen and reactive nitrogen species.

  Xenobiotica; the fate of foreign compounds in biological systems 20100501

• The pharmacokinetics of orally administered S-carboxymethyl-L-cysteine in the dog, calf and sheep.

  European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20100219

• Isoprostanes-biomarkers of lipid peroxidation: their utility in evaluating oxidative stress and analysis.

  International journal of molecular sciences 20100101

• Association between lung function and exacerbation frequency in patients with COPD.

  International journal of chronic obstructive pulmonary disease 20100101

• Modulation of the cellular expression of circulating advanced glycation end-product receptors in type 2 diabetic nephropathy.

  Experimental diabetes research 20100101

• Phenylalanine 4-monooxygenase and the role of endobiotic metabolism enzymes in xenobiotic biotransformation.

  Expert opinion on drug metabolism & toxicology 20091001

• Carbocisteine inhibits oxidant-induced apoptosis in cultured human airway epithelial cells.

  Respirology (Carlton, Vic.) 20090901

• L-carbocisteine reduces neutrophil elastase-induced mucin production.

  Respiratory physiology & neurobiology 20090630

• Carbocysteine: clinical experience and new perspectives in the treatment of chronic inflammatory diseases.

  Expert opinion on pharmacotherapy 20090301

• Acetylcysteine and carbocysteine for acute upper and lower respiratory tract infections in paediatric patients without chronic broncho-pulmonary disease.

  The Cochrane database of systematic reviews 20090121

• Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis.

  The Cochrane database of systematic reviews 20090121

• The activity of wild type and mutant phenylalanine hydroxylase with respect to the C-oxidation of phenylalanine and the S-oxidation of S-carboxymethyl-L-cysteine.

  Molecular genetics and metabolism 20090101

• Human phenylalanine monooxygenase and thioether metabolism.

  The Journal of pharmacy and pharmacology 20090101

• Carbocisteine can scavenge reactive oxygen species in vitro.

  Respirology (Carlton, Vic.) 20090101

• Mouse recombinant phenylalanine monooxygenase and the S-oxygenation of thioether substrates.

  Journal of biochemical and molecular toxicology 20090101

• Sequestration of Alkyltin(IV) compounds in aqueous solution: formation, stability, and empirical relationships for the binding of dimethyltin(IV) cation by N- and O-donor ligands.

  Bioinorganic chemistry and applications 20090101

• Measurement of phenylalanine monooxygenase (PAH) activities.

  Current protocols in toxicology 20090101

• The role for S-carboxymethylcysteine (carbocisteine) in the management of chronic obstructive pulmonary disease.

  International journal of chronic obstructive pulmonary disease 20081201

• Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.

  Journal of medicinal chemistry 20081113

• Carbocisteine for acute exacerbations of COPD.

  Lancet (London, England) 20081108

• Carbocisteine for acute exacerbations of COPD.

  Lancet (London, England) 20081108

• Variation in the attachment of Streptococcus pneumoniae to human pharyngeal epithelial cells after treatment with S-carboxymethylcysteine.

  Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 20080801

• A PEACE-ful solution to COPD exacerbations?

  Lancet (London, England) 20080614

• Effect of carbocisteine on acute exacerbation of chronic obstructive pulmonary disease (PEACE Study): a randomised placebo-controlled study.

  Lancet (London, England) 20080614

• Glutaraldehyde is an effective cross-linker for production of antibodies against advanced glycation end-products.

  Journal of immunological methods 20080520

• s-Carboxymethylcysteine inhibits carbachol-induced constriction of epithelium-denuded rat and human airway preparations.

  Clinical and experimental pharmacology & physiology 20080501

• Immunological detection of N omega-(Carboxymethyl)arginine by a specific antibody.

  Annals of the New York Academy of Sciences 20080401

• Usefulness of antibodies for evaluating the biological significance of AGEs.

  Annals of the New York Academy of Sciences 20080401

• Immunochemical detection of Nepsilon-(carboxyethyl)lysine using a specific antibody.

  Journal of immunological methods 20080320

• [Bitterness of the mixture of clarithromycin dry syrup and carbocisteine preparation--difference between brand name and generic drugs].

  Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20080301

• Influence of various combinations of mucolytic agent and non-ionic surfactant on intestinal absorption of poorly absorbed hydrophilic compounds.

  International journal of pharmaceutics 20080212

• S-CMC-Lys protective effects on human respiratory cells during oxidative stress.

  Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 20080101

• Phenylalanine 4-monooxygenase and the S-oxidation of S-carboxymethyl-L-cysteine by human cytosolic fractions.

  Drug metabolism and drug interactions 20080101

• Carbocisteine improves quality of life in patients with chronic obstructive pulmonary disease.

  Journal of the American Geriatrics Society 20071101

• The suppression of enhanced bitterness intensity of macrolide dry syrup mixed with an acidic powder.

  Chemical & pharmaceutical bulletin 20071001

• Mechanisms for the proton mobility-dependent gas-phase fragmentation reactions of S-alkyl cysteine sulfoxide-containing peptide ions.

  Journal of the American Society for Mass Spectrometry 20070901

• Bacterial lysate in the prevention of acute exacerbation of COPD and in respiratory recurrent infections.

  International journal of chronic obstructive pulmonary disease 20070901

• Plasma protein advanced glycation end products, carboxymethyl cysteine, and carboxyethyl cysteine, are elevated and related to nephropathy in patients with diabetes.

  Molecular and cellular biochemistry 20070801

• [A possible case of drug-induced pneumonia due to L-carbocisteine].

  Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society 20070801

• Synthesis and biological evaluation of L-cysteine derivatives as mitotic kinesin Eg5 inhibitors.

  Bioorganic & medicinal chemistry letters 20070715

• Fluorimetric determination of some sulfur containing compounds through complex formation with terbium (Tb+3) and uranium (U+3).

  Journal of fluorescence 20070501

• Carbocisteine: frequent cutaneous adverse effects.

  Prescrire international 20070201

• Reduction and s-carboxymethylation of proteins: large-scale method.

  CSH protocols 20070201

• Protein and low molecular mass thiols as targets and inhibitors of glycation reactions.

  Chemical research in toxicology 20061201

• Carbocysteine therapy in older people with chronic obstructive pulmonary disease.

  Journal of the American Geriatrics Society 20061101

• Evidence for inactivation of cysteine proteases by reactive carbonyls via glycation of active site thiols.

  The Biochemical journal 20060901

• Carbocisteine inhibits rhinovirus infection in human tracheal epithelial cells.

  The European respiratory journal 20060701

• Antioxidant therapeutic targets in COPD.

  Current drug targets 20060601

• Ambroxol for the prevention of acute upper respiratory disease.

  Clinical and experimental medicine 20060601

• A phase II study with antioxidants, both in the diet and supplemented, pharmaconutritional support, progestagen, and anti-cyclooxygenase-2 showing efficacy and safety in patients with cancer-related anorexia/cachexia and oxidative stress.

  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 20060501

• A comparative bioavailability study of a generic capsule formulation containing carbocysteine.

  Die Pharmazie 20060501

• Efficacy of S-carboxymethyl-L-cysteine for otitis media with effusion.

  Ear, nose, & throat journal 20060501

• The sulphoxidation of S-carboxymethyl-L-cysteine in COPD.

  The European respiratory journal 20060401

• Cerebral formation in situ of S-carboxymethylcysteine after ifosfamide administration to mice: a further clue to the mechanism of ifosfamide encephalopathy.

  Toxicology letters 20060301

• Antioxidant therapies in COPD.

  International journal of chronic obstructive pulmonary disease 20060301

• Thiodiglycolic acid and dermatological reactions following S-carboxymethyl-L-cysteine administration.

  The British journal of dermatology 20060201

• Carbocisteine reduces frequency of common colds and exacerbations in patients with chronic obstructive pulmonary disease.

  Journal of the American Geriatrics Society 20060201

• Effects of carbocisteine on sialyl-Lewis x expression in an airway carcinoma cell line stimulated with tumor necrosis factor-alpha.

  European journal of pharmacology 20060120

• S-CMC-Lys-dependent stimulation of electrogenic glutathione secretion by human respiratory epithelium.

  Journal of molecular medicine (Berlin, Germany) 20060101

• Synergistic effect of interleukin 1 alpha on nontypeable Haemophilus influenzae-induced up-regulation of human beta-defensin 2 in middle ear epithelial cells.

  BMC infectious diseases 20060101

• High-throughput determination of carbocysteine in human plasma by liquid chromatography/tandem mass spectrometry: application to a bioequivalence study of two formulations in healthy volunteers.

  Rapid communications in mass spectrometry : RCM 20060101

• An occupational hygiene investigation of exposure to acrylamide and the role for urinary S-carboxyethyl-cysteine (CEC) as a biological marker.

  The Annals of occupational hygiene 20051101

• S-carboxymethylcysteine normalises airway responsiveness in sensitised and challenged mice.

  The European respiratory journal 20051001

• Evidence for the formation of adducts and S-(carboxymethyl)cysteine on reaction of alpha-dicarbonyl compounds with thiol groups on amino acids, peptides, and proteins.

  Chemical research in toxicology 20050801

• Re(CO)(3) complexes synthesized via an improved preparation of aqueous fac-[Re(CO)(3)(H(2)O)(3)](+) as an aid in assessing (99m)Tc imaging agents. Structural characterization and solution behavior of complexes with thioether-bearing amino acids as tridentate ligands.

  Inorganic chemistry 20050725

• Thiodiglycolic acid as a possible causative agent of fixed drug eruption provoked only after continuous administration of S-carboxymethyl-L-cysteine: case report and review of reported cases.

  The British journal of dermatology 20050701

• Effect of glucose concentration on formation of AGEs in erythrocytes in vitro.

  Annals of the New York Academy of Sciences 20050601

• Analysis of plasma amino acids by HPLC with photodiode array and fluorescence detection.

  Clinica chimica acta; international journal of clinical chemistry 20050401

• [Fixed drug eruption and carbocysteine].

  Annales de dermatologie et de venereologie 20050401

• Phenylalanine 4-monooxygenase and the S-oxidation of S-carboxymethyl-L-cysteine in HepG2 cells.

  Drug metabolism and drug interactions 20050101

• Induction of cysteine dioxygenase activity by oral administration of cysteine analogues to the rat: implications for drug efficacy and safety.

  Drug metabolism and drug interactions 20050101

• Phenylalanine hydroxylase: possible involvement in the S-oxidation of S-carboxymethyl-l-cysteine.

  Analytical biochemistry 20041201

• Exhaled Interleukine-6 and 8-isoprostane in chronic obstructive pulmonary disease: effect of carbocysteine lysine salt monohydrate (SCMC-Lys).

  European journal of pharmacology 20041128

• N-acetylcysteine inhibits Na+ absorption across human nasal epithelial cells.

  Journal of cellular physiology 20041001

• Cancer-related anorexia/cachexia syndrome and oxidative stress: an innovative approach beyond current treatment.

  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 20041001

• Reduced airway inflammation and remodeling in parallel with mucin 5AC protein expression decreased by s-carboxymethylcysteine, a mucoregulant, in the airways of rats exposed to sulfur dioxide.

  International archives of allergy and immunology 20040801

• Lack of congruence between cysteine dioxygenase activity and S-carboxymethyl-L-cysteine S-oxidation activity in rat cytosol.

  The Journal of pharmacy and pharmacology 20040801

• Spectrophotometric determination of penicillamine and carbocisteine based on formation of metal complexes.

  Farmaco (Societa chimica italiana : 1989) 20040601

• Chemical modification of muscle protein in diabetes.

  Archives of biochemistry and biophysics 20040515

• Ion-chromatographic determination of carbocisteine in pharmaceuticals based on non-suppressed conductimetric detection.

  Journal of chromatography. A 20040213

• The effect of cysteine analogues on the excretion of urinary sulphate in the rat following cysteine administration.

  Drug metabolism and drug interactions 20040101

• Phenylalanine 4-monooxygenase and the S-oxidation of S-carboxymethyl-L-cysteine.

  Drug metabolism and drug interactions 20040101

• S-carboxymethylcysteine inhibits the attachment of Streptococcus pneumoniae to human pharyngeal epithelial cells.

  Microbial pathogenesis 20030601

• Effect of carbocysteine on cough reflex to capsaicin in asthmatic patients.

  British journal of clinical pharmacology 20030601

• Thirty-five cases of S-carboxymethylcysteine use in paraquat poisoning.

  Veterinary and human toxicology 20030201

• Determination of carbocysteine in human plasma by liquid chromatography/tandem mass spectrometry employing precolumn derivatization.

  Rapid communications in mass spectrometry : RCM 20030101

• Carbocysteine lysine salt monohydrate (SCMC-LYS) is a selective scavenger of reactive oxygen intermediates (ROIs).

  European cytokine network 20030101

• Subcutaneous interleukin-2 in combination with medroxyprogesterone acetate and antioxidants in advanced cancer responders to previous chemotherapy: phase II study evaluating clinical, quality of life, and laboratory parameters.

  Journal of experimental therapeutics & oncology 20030101

• Neurological toxicity of ifosfamide.

  Oncology 20030101

• An investigation into the inter-relationships of sulphur xeno-biotransformation pathways in Parkinson's and motor neurone diseases.

  Drug metabolism and drug interactions 20030101

• Degradation to sulphate of S-methyl-L-cysteine sulphoxide and S-carboxymethyl-L-cysteine sulphoxide in man.

  Drug metabolism and drug interactions 20030101

• [Mucolytic agents for acute respiratory tract infections in infants: a pharmacoepidemiologic problem?].

  Archives de pediatrie : organe officiel de la Societe francaise de pediatrie 20021101

• S-carboxymethylcysteine inhibits neutrophil activation mediated by N-formyl-methionyl-leucyl-phenylalanine.

  European journal of pharmacology 20020802

• Prolonged survival after experimental paraquat intoxication: role of alternative antioxidants.

  Veterinary and human toxicology 20020201

• Study on the inhibition of protein production by L-cysteine derivatives of nucleic acid bases.

  Nucleic acids research. Supplement (2001) 20020101

• Insights into the mechanisms of ifosfamide encephalopathy: drug metabolites have agonistic effects on alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)/kainate receptors and induce cellular acidification in mouse cortical neurons.

  The Journal of pharmacology and experimental therapeutics 20011201

• Antioxidant activity of carbocysteine lysine salt monohydrate.

  Panminerva medica 20010901

• Does early detection of otitis media with effusion prevent delayed language development?

  Archives of disease in childhood 20010801

• Effect of fudosteine, a cysteine derivative, on blood flow of tracheal microvasculature increased by airway inflammation.

  Environmental toxicology and pharmacology 20010701

• Effects of carbocysteine on antigen-induced increases in cough sensitivity and bronchial responsiveness in guinea pigs.

  The Journal of pharmacology and experimental therapeutics 20010601

• Direct determination of s-carboxymethyl-l-cysteine in syrups by reversed-phase high-performance liquid chromatography.

  Journal of pharmaceutical and biomedical analysis 20010401

• Modulating effects of mucoregulating drugs on the attachment of Haemophilus influenzae.

  Microbial pathogenesis 20010301

• [Comparative study of effects of anti-infective and respiratory system agents on endogeneous glucocorticoids with macrolides].

  The Japanese journal of antibiotics 20010201

• [Effects of carbocisteine on airway inflammation and related events in SO2-exposed rats].

  Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society 20010101

• Chemical and biochemical issues related to X-ray crystallography of the ligand-binding domain of estrogen receptor alpha.

  Bioconjugate chemistry 20010101

• A review of xenobiotic metabolism enzymes in Parkinson's disease and motor neuron disease.

  Drug metabolism and drug interactions 20010101

• S-carboxymethylcysteine in the treatment of glue ear: quantitative systematic review.

  BMC family practice 20010101

• Study about the inhibition of L-cysteine derivatives of nucleic acid bases in protein production.

  Nucleic acids research. Supplement (2001) 20010101

• Transfection of fluorescent probed antisense compounds: L-cysteine derivatives of nucleic acid bases.

  Nucleic acids research. Supplement (2001) 20010101

• A proposed mechanism for chlorpromazine jaundice--defective hepatic sulphoxidation combined with rapid hydroxylation.

  Journal of hepatology 19880801